Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21334068 | 0.91 | AAK1 (0.31) | AAK1 | |
| SCHEMBL2477577 | 0.79 | AAK1 (0.36) | AAK1 | |
| SCHEMBL9980531 | 0.79 | AAK1 (0.36) | AAK1 | |
| SCHEMBL15113477 | 0.74 | AAK1 (0.35) | AAK1 | |
| SCHEMBL19388453 | 0.72 | AAK1 (0.35) | AAK1 | |
| SCHEMBL10117913 | 0.71 | AAK1 (0.33) | AAK1 | |
| SCHEMBL2477578 | 0.70 | CCNE2 (0.39) | AAK1 | |
| SCHEMBL394604 | 0.68 | PAX8 (0.36) | — | |
| SCHEMBL10182576 | 0.68 | AAK1 (0.37) | AAK1 | |
| SCHEMBL16408070 | 0.68 | AAK1 (0.34) | AAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10407445-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2019-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10407445-B2 | Hepatitis C virus inhibitors | HAVCR2, SLC10A1, EIF2AK2 | AAK1 3505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.